NMRA Lawsuit Alert: Levi and Korsinsky Announce Class Action Against Neumora Therapeutics

Understanding Your Options After Suffering Losses from Neumora Therapeutics, Inc. (NMRA)

If you have recently experienced financial losses as a result of investing in Neumora Therapeutics, Inc. (NMRA) and are seeking information about potential recovery under federal securities laws, this article is for you. It is essential to be informed about your rights and possible remedies.

What Happened to Neumora Therapeutics, Inc. (NMRA)?

Neumora Therapeutics, Inc. is a biotechnology company specializing in the development of cannabinoid therapeutics. In 2025, the company disclosed material information that led to a significant decline in its stock price. The Securities and Exchange Commission (SEC) later initiated an investigation into potential securities law violations.

Potential Impact on Individual Investors

As an individual investor, you may be eligible to participate in a securities class action lawsuit against Neumora Therapeutics, Inc. (NMRA). If the case is successful, you could potentially receive compensation for your losses. The process begins with submitting a form, which can be accessed through the link below or by contacting attorney Joseph E. Levi, Esq.

How to Submit a Claim

To submit a claim, visit or contact Joseph E. Levi, Esq. at [email protected] or 425-451-4852. The deadline for filing a claim may vary, so it is crucial to act promptly.

Potential Impact on the Industry and the Market

The Neumora Therapeutics, Inc. (NMRA) situation could have far-reaching consequences for the biotechnology industry and the securities market as a whole. The outcome of this case could set a precedent for how similar cases are handled in the future. It also highlights the importance of accurate and timely disclosure of material information by publicly traded companies.

Conclusion

If you believe you have suffered losses as a result of investing in Neumora Therapeutics, Inc. (NMRA) and want to learn more about your potential recovery options under federal securities laws, take action now. Visit or contact Joseph E. Levi, Esq. to begin the process. Remember, the deadline for filing a claim may not last long, so do not delay.

This article is for informational purposes only and should not be considered legal advice. Always consult with a qualified securities attorney for advice regarding your specific situation.

• Visit or contact Joseph E. Levi, Esq. to submit a claim.
• Act promptly to ensure you meet the deadline for filing a claim.
• Consult with a qualified securities attorney for advice regarding your specific situation.